| 000 | 01432cam a2200277 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223031022.0 | ||
| 008 | 140809s2013 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aGift | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.34.M.Sc.2013.Sa.R | ||
| 100 | 0 | _aSalma Raouf Elmenawi | |
| 245 | 1 | 0 |
_aRole of thymoquinone in alzheimer's disease targeting the cholinergic system / _cSalma Raouf Elmenawi ; Supervised Ola Ahmed Heikal , Nesrine S. Elsayed |
| 260 |
_aCairo : _bSalma Raouf Elmenawi , _c2013 |
||
| 300 |
_a125 Leaves : _bcharts , facsimiles ; _c30cm |
||
| 502 | _aThesis (M.Sc.) - German University - Faculty of Postgraduate Studies and Scientific Research - Department of Pharmacology and Toxicology | ||
| 520 | _aAlzheimer's disease (AD) is a neurodegenerative disorder characterized by extracellular deposition of aggregated Ý amyloid protein (AÝ). Recently, correlation between nicotinic reseptors (nACHRs) dysfunction, neurodegeneration and cognitive deficits was shown in AD. nACHRs have protective role against AÝ toxicity while chronic inflammation damages cholinergic neurons and contributes to neurodegeneration | ||
| 700 | 0 |
_aNesrine S. Elsayed , _eSupervisor |
|
| 700 | 0 |
_aOla Ahmed Heikal , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c46764 _d46764 |
||